| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |